CA 125 normalization with chemotherapy is independently predictive of survival in advanced endometrial cancer

Gynecologic Oncology

Volumn 120, Issue 1, 2011, Pages 52-55

  Hoskins, P J ^a   Le, N ^a   Correa, R ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

CA 125; Chemotheraphy; Endometrial cancer

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CA-125 ANTIGEN; CARBOPLATIN; CARCINOMA, ENDOMETRIOID; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PACLITAXEL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78649908708     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.09.014     Document Type: Article

References (28)

1. E. Hogdall Cancer antigen 125 and prognosis Curr Opin Obstet Gynecol 20 2008 4 8
2. J.M. Duk, J.G. Aalders, G.J. Fleuren, and H.W. de Bruijn CA 125: a useful marker in endometrial carcinoma Am J Obstet Gynecol 155 1986 1097 1102
3. B. Patsner, W.J. Mann, H. Cohen, and M. Loesch Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma Am J Obstet Gynecol 158 1988 399 402
4. J.T. Soper, A. Berchuck, G.J. Olt, A.P. Soisson, D.L. Clarke-Pearson, and R.C. Bast Jr. Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma Am J Obstet Gynecol 163 1990 1204 1209
5. P. Lehtovirta, B. Cacciatore, and P. Ylostalo Serum CA 125 levels and sonography in the pre-operative assessment of myometrial invasion of endometrial cancer Br J Obstet Gynaecol 101 1994 532 535
6. G. Scambia, A. Gadducci, P.B. Panici, E. Foti, M. Ferdeghini, and G. Ferrandina Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma Gynecol Oncol 54 1994 292 297
7. N. Takeshima, Y. Shimizu, S. Umezawa, Y. Hirai, J.T. Chen, and I. Fujimoto Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma Gynecol Oncol 54 1994 321 326
8. S.S. Lo, D.K. Cheng, T.Y. Ng, L.C. Wong, and H.Y. Ngan Prognostic significance of tumour markers in endometrial cancer Tumour Biol 18 1997 241 249
9. A.K. Sood, R.E. Buller, R.A. Burger, J.D. Dawson, J.I. Sorosky, and M. Berman Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome Obstet Gynecol 90 1997 441 447
10. T. Kurihara, H. Mizunuma, M. Obara, K. Andoh, Y. Ibuki, and T. Nishimura Determination of a normal level of serum CA125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma Gynecol Oncol 69 1998 192 196
11. N.P. Koper, L.F. Massuger, C.M. Thomas, L.A. Kiemeney, and A.L. Verbeek Serum CA 125 measurements to identify patients with endometrial cancer who require lymphadenectomy Anticancer Res 18 1998 1897 1902
12. D.J. Dotters Preoperative CA 125 in endometrial cancer: is it useful? Am J Obstet Gynecol 182 2000 1328 1334
13. M.S. Lundstrom, C.K. Hogdall, A.L. Nielsen, and H.C. Nyholm Serum tetranectin and CA125 in endometrial adenocarcinoma Anticancer Res 20 2000 3903 3906
14. Y. Ebina, N. Sakuragi, H. Hareyama, Y. Todo, E. Nomura, and M. Takeda Para-aortic lymph node metastasis in relation to serum CA 125 levels and nuclear grade in endometrial carcinoma Acta Obstet Gynecol Scand 81 2002 458 465
15. S. Ginath, J. Menczer, Y. Fintsi, E. Ben-Shem, M. Glezerman, and I. Avinoach Tissue and serum CA125 expression in endometrial cancer Int J Gynecol Cancer 12 2002 372 375 (Pubitemid 34839835)
16. C.H. Hsieh, C.C. ChangChien, H. Lin, E.Y. Huang, C.C. Huang, and K.C. Lan Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol 86 2002 28 33
17. V. Kukura, G. Zovko, S. Ciglar, L. Markulin-Grgic, F. Santek, and M. Podgajski Serum CA-125 tumor marker in endometrial adenocarcinoma Eur J Gynaecol Oncol 24 2003 151 153
18. M. Yasuda, K. Saito, Y. Kobayashi, T. Muramatsu, T. Miyamoto, and M. Murakami Serum carbohydrate antigen elevations in endometrial adenocarcinomas: characterization of DU-PAN-2 expression as a tumor marker J Obstet Gynaecol Res 30 2004 59 64
19. J.L. Powell, K.A. Hill, B.C. Shiro, S.J. Diehl, and W.H. Gajewski Preoperative serum CA-125 levels in treating endometrial cancer J Reprod Med 50 2005 585 590
20. K. Yamazawa, K. Hirashiki, H. Usui, A. Mitsuhashi, H. Matsui, and S. Sekiya Discordance between serum level and tissue immunohistochemical staining of CA125 in endometrioid adenocarcinoma of the uterine corpus Int J Gynecol Pathol 24 2005 254 259
21. H.H. Chung, J.W. Kim, N.H. Park, Y.S. Song, S.B. Kang, and H.P. Lee Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer Acta Obstet Gynecol Scand 85 2006 1501 1505
22. D. Denschlag, L. Tan, S. Patel, A. Kerim-Dikeni, L. Souhami, and L. Gilbert Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome Am J Obstet Gynecol 196 2007 546.e1 546.e7
23. M. Honkavuori, A. Talvensaari-Mattila, Y. Soini, T. Turpeenniemi-Hujanen, and M. Santala MMP-2 expression associates with CA 125 and clinical course in endometrial carcinoma Gynecol Oncol 104 2007 217 221
24. Y. Todo, K. Okamoto, M. Hayashi, S. Minobe, E. Nomura, and H. Hareyama A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial cancer for tailoring the indication of lymphadenectomy Gynecol Oncol 104 2007 623 628
25. S.S. Han, S.H. Lee, D.H. Kim, J.W. Kim, N.H. Park, and S.B. Kang Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer Acta Obstet Gynecol Scand 89 2010 168 174
26. J.H. Shepherd Revised FIGO staging for gynaecological cancer Br J Obstet Gynaecol 96 1989 889 892
27. S.M. Crawford, and J. Peace Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary? Ann Oncol 16 2005 47 50
28. T. Alagoz, R.E. Buller, M. Berman, B. Anderson, A. Manetta, and P. DiSaia What is a normal CA125 level? Gynecol Oncol 53 1994 93 97